$TNXP
Tonix Pharmaceuticals Holding Corp.

2014 Q1 Form 10-K Financial Statement

#000114420414018823 Filed on March 28, 2014

View on sec.gov

Income Statement

Concept 2014 Q1 2012 Q4 2012
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $1.620M $1.220M $4.080M
YoY Change 28.57% -44.8% 83.78%
% of Gross Profit
Research & Development $3.550M $700.0K $2.584M
YoY Change 379.08% -39.66% 122.76%
% of Gross Profit
Depreciation & Amortization $4.000K $0.00 $14.00K
YoY Change 0.0% 40.0%
% of Gross Profit
Operating Expenses $5.169M $1.920M $6.662M
YoY Change 158.32% -43.03% 97.1%
Operating Profit -$5.169M -$6.662M
YoY Change
Interest Expense $10.00K -$710.0K -$2.790M
YoY Change 688.89% 3000.0%
% of Operating Profit
Other Income/Expense, Net $0.00 $0.00 $0.00
YoY Change
Pretax Income -$5.160M -$2.630M -$9.450M
YoY Change 158.0% -23.99% 172.33%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$5.164M -$2.630M -$9.450M
YoY Change 158.07% -23.99% 172.33%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$516.0M -$1.491B -$5.580B
COMMON SHARES
Basic Shares Outstanding 9.899M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2014 Q1 2012 Q4 2012
SHORT-TERM ASSETS
Cash & Short-Term Investments $49.50M $1.800M $1.790M
YoY Change 12275.0% 4375.0%
Cash & Equivalents $49.50M $1.785M $1.790M
Short-Term Investments
Other Short-Term Assets $600.0K $200.0K $220.0K
YoY Change 500.0% 100.0% 120.0%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $50.10M $2.010M $2.010M
YoY Change 9920.0% 1910.0% 1335.71%
LONG-TERM ASSETS
Property, Plant & Equipment $0.00 $47.00K $50.00K
YoY Change 66.67%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $100.0K $100.0K $60.00K
YoY Change 0.0% -66.67% -76.92%
Total Long-Term Assets $100.0K $107.0K $110.0K
YoY Change 0.0% -64.33% -62.07%
TOTAL ASSETS
Total Short-Term Assets $50.10M $2.010M $2.010M
Total Long-Term Assets $100.0K $107.0K $110.0K
Total Assets $50.20M $2.117M $2.120M
YoY Change 8266.67% 429.25% 393.02%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.400M $825.0K $830.0K
YoY Change 55.56% 17.86% 18.57%
Accrued Expenses $600.0K $310.0K $310.0K
YoY Change 100.0% 520.0%
Deferred Revenue
YoY Change
Short-Term Debt $300.0K $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $2.300M $1.138M $1.140M
YoY Change 91.67% 26.44% 22.58%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0% -100.0%
Other Long-Term Liabilities $0.00 $0.00 $20.00K
YoY Change -33.33%
Total Long-Term Liabilities $0.00 $0.00 $20.00K
YoY Change -100.0% -98.98%
TOTAL LIABILITIES
Total Short-Term Liabilities $2.300M $1.138M $1.140M
Total Long-Term Liabilities $0.00 $0.00 $20.00K
Total Liabilities $2.300M $1.158M $1.160M
YoY Change 91.67% -60.07% -59.72%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock $16.80M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $47.92M $959.0K $960.0K
YoY Change
Total Liabilities & Shareholders Equity $50.20M $2.117M $2.120M
YoY Change 8267.33% 429.25% 393.02%

Cashflow Statement

Concept 2014 Q1 2012 Q4 2012
OPERATING ACTIVITIES
Net Income -$5.164M -$2.630M -$9.450M
YoY Change 158.07% -23.99% 172.33%
Depreciation, Depletion And Amortization $4.000K $0.00 $14.00K
YoY Change 0.0% 40.0%
Cash From Operating Activities -$4.060M -$1.500M -$5.710M
YoY Change 198.53% 2.04% 116.29%
INVESTING ACTIVITIES
Capital Expenditures $2.000K $0.00 $36.00K
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 $0.00
YoY Change
Cash From Investing Activities $0.00 $0.00 -$40.00K
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $40.65M $6.933M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 45.41M 3.250M 7.490M
YoY Change 116.67% 186.97%
NET CHANGE
Cash From Operating Activities -4.060M -1.500M -5.710M
Cash From Investing Activities 0.000 0.000 -40.00K
Cash From Financing Activities 45.41M 3.250M 7.490M
Net Change In Cash 41.35M 1.750M 1.740M
YoY Change -3140.44% 5733.33% -5900.0%
FREE CASH FLOW
Cash From Operating Activities -$4.060M -$1.500M -$5.710M
Capital Expenditures $2.000K $0.00 $36.00K
Free Cash Flow -$4.062M -$1.500M -$5.746M
YoY Change 198.68% 2.04% 117.65%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2013Q4 us-gaap Assets Current
AssetsCurrent
8631000 USD
CY2012Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
47000 USD
CY2012Q4 us-gaap Cash
Cash
1785000 USD
CY2013Q4 us-gaap Cash
Cash
8202000 USD
CY2012Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
225000 USD
CY2013Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
429000 USD
CY2012Q4 us-gaap Assets Current
AssetsCurrent
2010000 USD
CY2013Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
45000 USD
CY2012Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
60000 USD
CY2013Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
60000 USD
CY2012Q4 us-gaap Assets
Assets
2117000 USD
CY2013Q4 us-gaap Assets
Assets
8736000 USD
CY2012Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
825000 USD
CY2013Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
765000 USD
CY2012Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
310000 USD
CY2013Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1166000 USD
CY2013Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2012Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2013Q4 us-gaap Common Stock Value
CommonStockValue
6000 USD
CY2012Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
16801000 USD
CY2013Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2211000 USD
CY2012Q4 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
20000 USD
CY2013Q4 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
13000 USD
CY2012Q4 us-gaap Liabilities
Liabilities
1158000 USD
CY2013Q4 us-gaap Liabilities
Liabilities
2224000 USD
CY2012Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2013Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2012Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2013Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2013Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
33235000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
3269000 USD
CY2012 tnxp Issuance Of Common Stock To Intellectual Property
IssuanceOfCommonStockToIntellectualProperty
0 USD
CY2013 tnxp Issuance Of Common Stock To Intellectual Property
IssuanceOfCommonStockToIntellectualProperty
0 USD
CY2012Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2013Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2012Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2013Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2012Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000 shares
CY2013Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000 shares
CY2012Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2159159 shares
CY2013Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5823081 shares
CY2012Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2159159 shares
CY2013Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5823081 shares
CY2012Q4 us-gaap Interest Payable Current
InterestPayableCurrent
3000 USD
CY2013Q4 us-gaap Interest Payable Current
InterestPayableCurrent
0 USD
CY2012Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1138000 USD
CY2012Q4 us-gaap Common Stock Value
CommonStockValue
2000 USD
CY2012Q4 us-gaap Stockholders Equity
StockholdersEquity
959000 USD
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
6512000 USD
CY2012Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2117000 USD
CY2013Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
8736000 USD
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
376500 shares
CY2013 tnxp Reverse Stock Split Effective Date
ReverseStockSplitEffectiveDate
2013-05-01
CY2013 us-gaap Use Of Estimates
UseOfEstimates
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <u><font style="FONT-SIZE: 10pt; COLOR: black">Use of estimates</font></u></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"> <font style="COLOR: black; FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="COLOR: black; FONT-SIZE: 10pt">The preparation of financial statements in accordance with&#160;accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates include the useful life of fixed assets, assumptions used in the fair value of stock-based compensation and other equity instruments, <font style="FONT-FAMILY: 'Times New Roman','serif'; COLOR: black; FONT-SIZE: 10pt"> and the percent of completion of research and development contracts</font>.</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2012Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
78535 USD
CY2013Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
93188 USD
CY2012Q4 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
7000 USD
CY2013Q4 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
46000 USD
CY2012Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2013Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2012Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2013Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2013Q4 tnxp Working Capital Amount
WorkingCapitalAmount
7000000 USD
CY2012Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
1259934 shares
CY2013Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
3137656 shares
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
150000 shares
CY2012Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
31641 USD
CY2013Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
48232 USD
CY2012Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
60000 USD
CY2013Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
60000 USD
CY2013 us-gaap Fair Value Assumptions Expected Dividend Rate
FairValueAssumptionsExpectedDividendRate
0 pure
CY2012 tnxp Warrants Exercise Terms And Expiration Description
WarrantsExerciseTermsAndExpirationDescription
In the event that the Companys average daily volume weighted average price was at or above $15.00 during the Measuring Period, the Class B Warrants were to expire unexercised. The Announcement Date was the earlier of (1) the date on which the Company announces via press release the results of the pharmacokinetic study of TNX-102 gelcap; or (2) June 1, 2012. On April 5, 2012 the Company issued a press release announcing the results of the pharmacokinetic study of TNX-102 gelcap, which is defined as an Announcement Date for the purpose of the Class B Warrants. Based on the Companys average daily volume weighted average price of $34.60 per share during the Measuring Period, the Class B Warrants expired unexercised.
CY2012 tnxp Stock Units Issued Upon Conversion Of Convertible Debt Purchase Price
StockUnitsIssuedUponConversionOfConvertibleDebtPurchasePrice
25000 USD
CY2012 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2584000 USD
CY2013 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4650000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
9185000 USD
CY2012 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4078000 USD
CY2013 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6238000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
14572000 USD
CY2012 us-gaap Operating Expenses
OperatingExpenses
6662000 USD
CY2013 us-gaap Operating Expenses
OperatingExpenses
10888000 USD
us-gaap Operating Expenses
OperatingExpenses
23757000 USD
CY2012 us-gaap Operating Income Loss
OperatingIncomeLoss
-6662000 USD
CY2013 us-gaap Operating Income Loss
OperatingIncomeLoss
-10888000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-23757000 USD
CY2012 us-gaap Extinguishment Of Debt Gain Loss Net Of Tax
ExtinguishmentOfDebtGainLossNetOfTax
0 USD
CY2013 us-gaap Extinguishment Of Debt Gain Loss Net Of Tax
ExtinguishmentOfDebtGainLossNetOfTax
0 USD
us-gaap Extinguishment Of Debt Gain Loss Net Of Tax
ExtinguishmentOfDebtGainLossNetOfTax
8000 USD
CY2012 us-gaap Other Income
OtherIncome
2000 USD
CY2013 us-gaap Other Income
OtherIncome
0 USD
us-gaap Other Income
OtherIncome
2000 USD
CY2012 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-1177000 USD
CY2013 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
0 USD
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-1177000 USD
CY2012 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-1613000 USD
CY2013 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
4000 USD
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-1804000 USD
CY2012 us-gaap Net Income Loss
NetIncomeLoss
-9450000 USD
CY2013 us-gaap Net Income Loss
NetIncomeLoss
-10884000 USD
us-gaap Net Income Loss
NetIncomeLoss
-26728000 USD
CY2012 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-5.58
CY2013 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-3.37
CY2012 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
1693416 shares
CY2013 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
3231311 shares
CY2012 us-gaap Debt Instrument Convertible Beneficial Conversion Feature
DebtInstrumentConvertibleBeneficialConversionFeature
710000 USD
CY2012Q4 tnxp Debt Instrument Convertible Original Conversion Price
DebtInstrumentConvertibleOriginalConversionPrice
1.00
CY2012Q4 tnxp Debt Instrument Convertible Stock Price
DebtInstrumentConvertibleStockPrice
0.51
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
0.0187 pure
CY2012 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y6M
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.9589 pure
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Payments
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments
0.0 USD
CY2011Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
0 shares
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
175000 shares
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
226500 shares
CY2012 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0 shares
CY2013 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0 shares
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
25000 shares
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
0 shares
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
376500 shares
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
79167 shares
CY2011Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
CY2012 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
30.00
CY2013 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
10.20
CY2012 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2013 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
30.00
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
30.00
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
18.09
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
18.09
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
30.00
CY2012 tnxp Share Based Compensation Arrangement By Share Based Payment Award Options Granted Weighted Average Remaining Contractual Term
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm
P10Y
CY2013 tnxp Share Based Compensation Arrangement By Share Based Payment Award Options Granted Weighted Average Remaining Contractual Term
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm
P10Y
CY2012 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P9Y4M6D
CY2013 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y9M22D
CY2013 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P8Y9M22D
CY2013 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P8Y4M10D
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Grant Date Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue
0
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Grant Date Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue
0
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
USD
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
USD
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0 USD
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
24915 USD
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
24915 USD
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
0 USD
CY2013Q4 tnxp Closing Stock Price
ClosingStockPrice
10.31
CY2013Q1 tnxp Warrants Exercise Price
WarrantsExercisePrice
12.00
CY2013Q4 tnxp Warrants Exercise Price
WarrantsExercisePrice
4.25
CY2013Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
232232 USD
CY2012Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
5207759 USD
CY2013Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
9040045 USD
CY2012Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
147003 USD
CY2013Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
383053 USD
CY2012Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
5360950 USD
CY2012 tnxp Stock Issuance Costs
StockIssuanceCosts
436000 USD
CY2012 tnxp Stock Issued During Period To Holders Of Convertible Debentures Per Share Two
StockIssuedDuringPeriodToHoldersOfConvertibleDebenturesPerShareTwo
6
CY2012 tnxp Common Stock Issued During Period Per Share Two
CommonStockIssuedDuringPeriodPerShareTwo
8
CY2012 tnxp Common And Warrants Issue Expenses
CommonAndWarrantsIssueExpenses
70000 USD
CY2012 us-gaap Depreciation
Depreciation
14000 USD
CY2013Q1 tnxp Warrants Issued During Period To Purchase Common Stock
WarrantsIssuedDuringPeriodToPurchaseCommonStock
10800 shares
CY2013Q4 tnxp Warrants Issued During Period To Purchase Common Stock
WarrantsIssuedDuringPeriodToPurchaseCommonStock
3185 shares
CY2007Q2 us-gaap Stockholders Equity
StockholdersEquity
0 USD
CY2013Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
131513 USD
CY2013Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
100719 USD
CY2010 tnxp Operating Leases Expiration Period
OperatingLeasesExpirationPeriod
P5Y
CY2010Q3 tnxp Operating Leases Periodic Payment One To Four Years
OperatingLeasesPeriodicPaymentOneToFourYears
10000 USD
CY2010Q3 tnxp Operating Leases Periodic Payment Year Five
OperatingLeasesPeriodicPaymentYearFive
11000 USD
CY2011Q1 us-gaap Operating Leases Income Statement Lease Revenue
OperatingLeasesIncomeStatementLeaseRevenue
9420 USD
CY2010Q4 us-gaap Operating Leases Income Statement Lease Revenue
OperatingLeasesIncomeStatementLeaseRevenue
9420 USD
CY2010Q4 us-gaap Operating Leases Income Statement Lease Revenue
OperatingLeasesIncomeStatementLeaseRevenue
9420 USD
CY2010Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
60000 USD
CY2012 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
116732 USD
CY2013 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
116569 USD
CY2012Q4 us-gaap Deferred Rent Credit
DeferredRentCredit
26156 USD
CY2013Q4 us-gaap Deferred Rent Credit
DeferredRentCredit
19710 USD
CY2012Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
6188 USD
CY2013Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
6188 USD
CY2013Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
9429286 USD
CY2012Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
5360950 USD
CY2013Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
9429286 USD
CY2012Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 USD
CY2013Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 USD
CY2012 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.340 pure
CY2013 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.340 pure
CY2012 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.059 pure
CY2013 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.105 pure
CY2012 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
0.050 pure
CY2013 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
0.067 pure
CY2012 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.349 pure
CY2013 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.378 pure
CY2012 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0 pure
CY2013 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0 pure
CY2012 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
2891718 USD
CY2013 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
4068336 USD
CY2010 tnxp Stock Issued During Period To Founders For Intellectual Property Per Share
StockIssuedDuringPeriodToFoundersForIntellectualPropertyPerShare
4.52
tnxp Stock Issued During Period To Founders For Intellectual Property Per Share
StockIssuedDuringPeriodToFoundersForIntellectualPropertyPerShare
3
CY2011 tnxp Stock Issued During Period For Services Rendered Per Share
StockIssuedDuringPeriodForServicesRenderedPerShare
7.2
tnxp Stock Issued During Period For Services Rendered Per Share
StockIssuedDuringPeriodForServicesRenderedPerShare
3
CY2009 tnxp Stock Issued During Period On Conversion Of Convertible Securities Net Of Adjustments Per Share
StockIssuedDuringPeriodOnConversionOfConvertibleSecuritiesNetOfAdjustmentsPerShare
2.6
CY2009 tnxp Stock Issued During Period For Directors Employees And Consultants Per Share
StockIssuedDuringPeriodForDirectorsEmployeesAndConsultantsPerShare
3
CY2010 tnxp Stock Issued During Period For Directors Employees And Consultants Per Share
StockIssuedDuringPeriodForDirectorsEmployeesAndConsultantsPerShare
4.76
CY2011 tnxp Stock Issued During Period For Directors Employees And Consultants Per Share
StockIssuedDuringPeriodForDirectorsEmployeesAndConsultantsPerShare
4.6
CY2010 tnxp Stock Issued During Period On Conversion Of Convertible Demand Notes Net Of Adjustments Per Share
StockIssuedDuringPeriodOnConversionOfConvertibleDemandNotesNetOfAdjustmentsPerShare
4.6
CY2010 tnxp Stock Issued During Period On Conversion Of Convertible Accrued Interest Net Of Adjustments Per Share
StockIssuedDuringPeriodOnConversionOfConvertibleAccruedInterestNetOfAdjustmentsPerShare
4.6
CY2010 tnxp Capital Stock Issued During Period Per Share
CapitalStockIssuedDuringPeriodPerShare
4.6
CY2011 tnxp Capital Preferred Stock Issued During Period Per Share
CapitalPreferredStockIssuedDuringPeriodPerShare
4.6
CY2012 tnxp Stock Issued During Period To Holders Of Convertible Debentures Per Share One
StockIssuedDuringPeriodToHoldersOfConvertibleDebenturesPerShareOne
12.4
CY2012 tnxp Common Stock Issued During Period Per Share One
CommonStockIssuedDuringPeriodPerShareOne
12.4
CY2013 us-gaap Depreciation
Depreciation
17000 USD
us-gaap Depreciation
Depreciation
49000 USD
CY2012 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
196000 USD
CY2013 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
0 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
250000 USD
CY2012 tnxp Beneficial Conversion Feature In Connection With Convertible Debentures
BeneficialConversionFeatureInConnectionWithConvertibleDebentures
710000 USD
CY2013 tnxp Beneficial Conversion Feature In Connection With Convertible Debentures
BeneficialConversionFeatureInConnectionWithConvertibleDebentures
0 USD
tnxp Beneficial Conversion Feature In Connection With Convertible Debentures
BeneficialConversionFeatureInConnectionWithConvertibleDebentures
710000 USD
CY2012 tnxp Common Stock Issued In Connection With Convertible Debentures
CommonStockIssuedInConnectionWithConvertibleDebentures
426000 USD
CY2013 tnxp Common Stock Issued In Connection With Convertible Debentures
CommonStockIssuedInConnectionWithConvertibleDebentures
0 USD
tnxp Common Stock Issued In Connection With Convertible Debentures
CommonStockIssuedInConnectionWithConvertibleDebentures
426000 USD
CY2012 tnxp Warrants Issued In Connection With Convertible Debentures
WarrantsIssuedInConnectionWithConvertibleDebentures
81000 USD
CY2013 tnxp Warrants Issued In Connection With Convertible Debentures
WarrantsIssuedInConnectionWithConvertibleDebentures
0 USD
tnxp Warrants Issued In Connection With Convertible Debentures
WarrantsIssuedInConnectionWithConvertibleDebentures
81000 USD
CY2012 us-gaap Share Based Compensation
ShareBasedCompensation
865000 USD
CY2013 us-gaap Share Based Compensation
ShareBasedCompensation
1717000 USD
tnxp Issuance Of Common Stock To Intellectual Property
IssuanceOfCommonStockToIntellectualProperty
383000 USD
CY2012 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
CY2013 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
8000 USD
CY2012 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
122000 USD
CY2013 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
204000 USD
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
429000 USD
CY2012 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
132000 USD
CY2013 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-60000 USD
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
766000 USD
CY2012 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
-32000 USD
CY2013 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
-3000 USD
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
3000 USD
CY2012 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
293000 USD
CY2013 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
856000 USD
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
1260000 USD
CY2012 us-gaap Increase Decrease In Deferred Liabilities
IncreaseDecreaseInDeferredLiabilities
-3000 USD
CY2013 us-gaap Increase Decrease In Deferred Liabilities
IncreaseDecreaseInDeferredLiabilities
-7000 USD
us-gaap Increase Decrease In Deferred Liabilities
IncreaseDecreaseInDeferredLiabilities
19000 USD
CY2012 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-5713000 USD
CY2013 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-8517000 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-18721000 USD
CY2012 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
36000 USD
CY2013 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
15000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
94000 USD
CY2012 tnxp Repayments Of Restricted Cash
RepaymentsOfRestrictedCash
0 USD
CY2013 tnxp Repayments Of Restricted Cash
RepaymentsOfRestrictedCash
0 USD
tnxp Repayments Of Restricted Cash
RepaymentsOfRestrictedCash
60000 USD
CY2012 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-36000 USD
CY2013 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-15000 USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-154000 USD
CY2012 us-gaap Proceeds From Other Short Term Debt
ProceedsFromOtherShortTermDebt
0 USD
CY2013 us-gaap Proceeds From Other Short Term Debt
ProceedsFromOtherShortTermDebt
0 USD
us-gaap Proceeds From Other Short Term Debt
ProceedsFromOtherShortTermDebt
480000 USD
CY2012 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
320000 USD
CY2013 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
0 USD
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
1020000 USD
CY2012 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
390000 USD
CY2013 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
0 USD
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
1891000 USD
CY2012 us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
150000 USD
CY2013 us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
0 USD
us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
150000 USD
CY2012 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
6933000 USD
CY2013 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
10042000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
16975000 USD
CY2012 tnxp Proceeds From Issuance Of Capital Stock
ProceedsFromIssuanceOfCapitalStock
0 USD
CY2013 tnxp Proceeds From Issuance Of Capital Stock
ProceedsFromIssuanceOfCapitalStock
0 USD
tnxp Proceeds From Issuance Of Capital Stock
ProceedsFromIssuanceOfCapitalStock
1954000 USD
CY2012 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
7493000 USD
CY2013 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
14950000 USD
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
27078000 USD
CY2012 us-gaap Cash Period Increase Decrease
CashPeriodIncreaseDecrease
1744000 USD
CY2013 us-gaap Cash Period Increase Decrease
CashPeriodIncreaseDecrease
6417000 USD
us-gaap Cash Period Increase Decrease
CashPeriodIncreaseDecrease
8202000 USD
CY2011Q4 us-gaap Cash
Cash
41000 USD
CY2007Q2 us-gaap Cash
Cash
0 USD
CY2012 us-gaap Interest Paid
InterestPaid
35000 USD
CY2013 us-gaap Interest Paid
InterestPaid
3000 USD
us-gaap Interest Paid
InterestPaid
38000 USD
CY2012 tnxp Convertible Notes Exchanged For Preferred Shares
ConvertibleNotesExchangedForPreferredShares
0 USD
CY2013 tnxp Convertible Notes Exchanged For Preferred Shares
ConvertibleNotesExchangedForPreferredShares
0 USD
tnxp Convertible Notes Exchanged For Preferred Shares
ConvertibleNotesExchangedForPreferredShares
200000 USD
CY2012 tnxp Capital Contribution Of Accrued Interest
CapitalContributionOfAccruedInterest
0 USD
CY2013 tnxp Capital Contribution Of Accrued Interest
CapitalContributionOfAccruedInterest
0 USD
tnxp Capital Contribution Of Accrued Interest
CapitalContributionOfAccruedInterest
27000 USD
CY2012 tnxp Demand Notes And Accrued Interest Converted In To Capital Stock
DemandNotesAndAccruedInterestConvertedInToCapitalStock
0 USD
CY2013 tnxp Demand Notes And Accrued Interest Converted In To Capital Stock
DemandNotesAndAccruedInterestConvertedInToCapitalStock
0 USD
tnxp Demand Notes And Accrued Interest Converted In To Capital Stock
DemandNotesAndAccruedInterestConvertedInToCapitalStock
549000 USD
CY2012 tnxp Common Stock Issued For Deferred Financing Costs
CommonStockIssuedForDeferredFinancingCosts
0 USD
CY2013 tnxp Common Stock Issued For Deferred Financing Costs
CommonStockIssuedForDeferredFinancingCosts
0 USD
tnxp Common Stock Issued For Deferred Financing Costs
CommonStockIssuedForDeferredFinancingCosts
144000 USD
CY2012 us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
320000 USD
CY2013 us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
0 USD
us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
820000 USD
CY2012 tnxp Adjustment To Additional Paid In Capital Reclassification Of Warrants To Equity
AdjustmentToAdditionalPaidInCapitalReclassificationOfWarrantsToEquity
3939000 USD
CY2013 tnxp Adjustment To Additional Paid In Capital Reclassification Of Warrants To Equity
AdjustmentToAdditionalPaidInCapitalReclassificationOfWarrantsToEquity
0 USD
tnxp Adjustment To Additional Paid In Capital Reclassification Of Warrants To Equity
AdjustmentToAdditionalPaidInCapitalReclassificationOfWarrantsToEquity
3939000 USD
CY2012 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
2635000 USD
CY2013 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
0 USD
us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
2635000 USD
CY2011 us-gaap Debt Issuance Costs
DebtIssuanceCosts
24000 USD
CY2012 us-gaap Debt Issuance Costs
DebtIssuanceCosts
USD
CY2013 us-gaap Debt Issuance Costs
DebtIssuanceCosts
USD
CY2011 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
USD
CY2012Q4 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
0 USD
CY2013Q4 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
280000 USD
CY2012Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
0 USD
CY2013Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1000 USD
CY2012 us-gaap Effect Of Exchange Rate On Cash
EffectOfExchangeRateOnCash
0 USD
CY2013 us-gaap Effect Of Exchange Rate On Cash
EffectOfExchangeRateOnCash
-1000 USD
us-gaap Effect Of Exchange Rate On Cash
EffectOfExchangeRateOnCash
-1000 USD
CY2012 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
0 USD
CY2013 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
280000 USD
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
280000 USD
CY2012 tnxp Proceeds From Issuance Of Common Stock1
ProceedsFromIssuanceOfCommonStock1
0 USD
CY2013 tnxp Proceeds From Issuance Of Common Stock1
ProceedsFromIssuanceOfCommonStock1
4628000 USD
tnxp Proceeds From Issuance Of Common Stock1
ProceedsFromIssuanceOfCommonStock1
4628000 USD
CY2013 dei Document Type
DocumentType
10-K
CY2013 dei Amendment Flag
AmendmentFlag
false
CY2013 dei Document Period End Date
DocumentPeriodEndDate
2013-12-31
CY2013 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2013
CY2013 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2013 dei Trading Symbol
TradingSymbol
TNXP
CY2014Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
9899497 shares
CY2013 dei Entity Registrant Name
EntityRegistrantName
Tonix Pharmaceuticals Holding Corp.
CY2013 dei Entity Central Index Key
EntityCentralIndexKey
0001430306
CY2013 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2013 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2013 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2013 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2013 dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
CY2013Q2 dei Entity Public Float
EntityPublicFloat
9146524 USD
CY2013 tnxp Description Of Unit
DescriptionOfUnit
Each Unit consisted of (i) one share of common stock and (ii) one Series A Warrant (the Warrants) to purchase one share of common stock.
CY2013 tnxp Description Of Option Granted Under Underwriting Agreement
DescriptionOfOptionGrantedUnderUnderwritingAgreement
the Company also granted the Underwriters an option for a period of 45 days to purchase up to (i) 402,000 additional Units or (ii) 402,000 additional shares of common stock and/or additional Warrants to purchase up to 402,000 shares of common stock, on the same terms, to cover over-allotments, if any.
CY2013 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
20-for-1
CY2013Q4 tnxp Shares Outstanding Before Reverse Stock Split
SharesOutstandingBeforeReverseStockSplit
43182599 shares
CY2013 us-gaap Stockholders Equity Note Changes In Capital Structure Subsequent Changes To Number Of Common Shares
StockholdersEquityNoteChangesInCapitalStructureSubsequentChangesToNumberOfCommonShares
2159159 shares
CY2013 us-gaap Adjustments To Additional Paid In Capital Stock Split
AdjustmentsToAdditionalPaidInCapitalStockSplit
41024 USD
CY2013 tnxp Warrants Exercise Price
WarrantsExercisePrice
8
CY2013 tnxp Warrants Exercise Price1
WarrantsExercisePrice1
4.25
CY2012 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
0 USD
CY2013 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
51000 USD
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
51000 USD
CY2012Q4 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
0.30
CY2013 tnxp Compensation Related To Vested Warrants
CompensationRelatedToVestedWarrants
51114 USD
CY2013Q4 us-gaap Development Stage Enterprise Deficit Accumulated During Development Stage
DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage
26728000 USD
CY2012Q4 us-gaap Development Stage Enterprise Deficit Accumulated During Development Stage
DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage
15844000 USD
CY2013Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
491000 USD
CY2012Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
21000 USD
tnxp Stock Issued During Period Value To Founders For Intellectual Property
StockIssuedDuringPeriodValueToFoundersForIntellectualProperty
88000 USD
tnxp Stock Issued During Period Value For Directors Employees And Consultants
StockIssuedDuringPeriodValueForDirectorsEmployeesAndConsultants
24000 USD
us-gaap Net Income Loss
NetIncomeLoss
-537000 USD
CY2007Q4 us-gaap Stockholders Equity
StockholdersEquity
-415000 USD
CY2008 us-gaap Net Income Loss
NetIncomeLoss
-202000 USD
CY2008Q4 us-gaap Stockholders Equity
StockholdersEquity
-545000 USD
CY2009 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities Net Of Adjustments
StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments
201000 USD
CY2009 tnxp Stock Issued During Period Value For Directors Employees And Consultants
StockIssuedDuringPeriodValueForDirectorsEmployeesAndConsultants
4000 USD
CY2009 tnxp Adjustments To Additional Paid In Capital Capital Contribution
AdjustmentsToAdditionalPaidInCapitalCapitalContribution
24000 USD
CY2009 us-gaap Net Income Loss
NetIncomeLoss
-221000 USD
CY2009Q4 us-gaap Stockholders Equity
StockholdersEquity
-537000 USD
us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
10000 USD
CY2008 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
72000 USD
CY2010 tnxp Stock Issued During Period Value Conversion Of Convertible Notes Net Of Adjustments
StockIssuedDuringPeriodValueConversionOfConvertibleNotesNetOfAdjustments
480000 USD
CY2010 tnxp Stock Issued During Period Value Conversion Of Convertible Accrued Interest Net Of Adjustments
StockIssuedDuringPeriodValueConversionOfConvertibleAccruedInterestNetOfAdjustments
69000 USD
CY2010 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1342000 USD
CY2010 tnxp Stock Issued During Period Value To Founders For Intellectual Property
StockIssuedDuringPeriodValueToFoundersForIntellectualProperty
295000 USD
CY2010 tnxp Stock Issued During Period Value For Directors Employees And Consultants
StockIssuedDuringPeriodValueForDirectorsEmployeesAndConsultants
140000 USD
CY2010 us-gaap Net Income Loss
NetIncomeLoss
-1964000 USD
CY2010Q4 us-gaap Stockholders Equity
StockholdersEquity
-175000 USD
CY2011 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
612000 USD
CY2011 tnxp Stock Issued During Period Value For Directors Employees And Consultants
StockIssuedDuringPeriodValueForDirectorsEmployeesAndConsultants
435000 USD
CY2011 tnxp Stock Issued During Period Value In Connection With Share Exchange Transaction
StockIssuedDuringPeriodValueInConnectionWithShareExchangeTransaction
0 USD
CY2011 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
144000 USD
CY2011 us-gaap Net Income Loss
NetIncomeLoss
-3470000 USD
CY2011Q4 us-gaap Stockholders Equity
StockholdersEquity
-2454000 USD
CY2012 tnxp Stock Issued During Period Value To Holders Of Convertible Debentures One
StockIssuedDuringPeriodValueToHoldersOfConvertibleDebenturesOne
369000 USD
CY2012 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
3633000 USD
CY2012 tnxp Adjustments To Additional Paid In Capital Warrants Issued To Holders Of Convertible Debentures
AdjustmentsToAdditionalPaidInCapitalWarrantsIssuedToHoldersOfConvertibleDebentures
83000 USD
CY2012 tnxp Adjustments To Additional Paid In Capital Warrants Issued To Placement Agent
AdjustmentsToAdditionalPaidInCapitalWarrantsIssuedToPlacementAgent
6000 USD
CY2012 tnxp Adjustments To Additional Paid In Capital Warrants Reclassified To Equity
AdjustmentsToAdditionalPaidInCapitalWarrantsReclassifiedToEquity
3939000 USD
CY2012 tnxp Stock Issued During Period Value To Holders Of Convertible Debentures Two
StockIssuedDuringPeriodValueToHoldersOfConvertibleDebenturesTwo
710000 USD
CY2012 tnxp Stock Issued During Period Value New Issues One
StockIssuedDuringPeriodValueNewIssuesOne
2545000 USD
CY2012 us-gaap Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
710000 USD
CY2012 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
3000 USD
CY2012 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
865000 USD
CY2013 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
1717000 USD
CY2013 tnxp Stock Issued During Period Value Warrants Exercised
StockIssuedDuringPeriodValueWarrantsExercised
307000 USD
CY2013 tnxp Stock Issued During Period Value Warrants Exercised1
StockIssuedDuringPeriodValueWarrantsExercised1
10042000 USD
CY2013 tnxp Stock Issued During Period Value In Exchange For Exercise Of Warrants Transaction One
StockIssuedDuringPeriodValueInExchangeForExerciseOfWarrantsTransactionOne
3761000 USD
CY2013 tnxp Stock Issued During Period Value In Exchange For Exercise Of Warrants Transaction Two
StockIssuedDuringPeriodValueInExchangeForExerciseOfWarrantsTransactionTwo
560000 USD
CY2013 tnxp Stock Issued During Period Value In Exchange For Exercise Of Warrants On Cashless Basis
StockIssuedDuringPeriodValueInExchangeForExerciseOfWarrantsOnCashlessBasis
0 USD
CY2013 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
51000 USD
CY2013 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
1352000 USD
CY2013 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-1000 USD
CY2012 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
0 USD
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-1000 USD
CY2013 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-10885000 USD
CY2012 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-9450000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-26729000 USD
CY2012 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
506000 USD
CY2013 us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
-1000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
-1000 USD
CY2013Q4 tnxp Common Stock Shares To Be Issued
CommonStockSharesToBeIssued
11002 shares
CY2013 tnxp Proceeds From Sale Of Common Stock And Warrants
ProceedsFromSaleOfCommonStockAndWarrants
10000000 USD
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
0.0202 pure
CY2013 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.9996 pure
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Payments
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments
0.0 USD
CY2013Q4 tnxp Consulting Agreements Commitments Outstanding Amount
ConsultingAgreementsCommitmentsOutstandingAmount
4500000 USD

Files In Submission

Name View Source Status
0001144204-14-018823-index-headers.html Edgar Link pending
0001144204-14-018823-index.html Edgar Link pending
0001144204-14-018823.txt Edgar Link pending
0001144204-14-018823-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
ft0001img-1.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tnxp-20131231.xml Edgar Link completed
tnxp-20131231.xsd Edgar Link pending
tnxp-20131231_cal.xml Edgar Link unprocessable
tnxp-20131231_def.xml Edgar Link unprocessable
tnxp-20131231_lab.xml Edgar Link unprocessable
tnxp-20131231_pre.xml Edgar Link unprocessable
v369823_10k.htm Edgar Link pending
v369823_ex23-01.htm Edgar Link pending
v369823_ex31-01.htm Edgar Link pending
v369823_ex31-02.htm Edgar Link pending
v369823_ex32-01.htm Edgar Link pending